Atsuki Kume

Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy

Wataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2016 · 42 citations

Medicine, Ophthalmology, Pharmacotherapy +12

Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration

Yoichi Sakurada, Seigo Yoneyama, Atsushi Sugiyama et al. · PLoS ONE · 2016 · 39 citations · Full text

Medicine, Genetics, Ophthalmology +17

CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

Yoichi Sakurada, Atsushi Sugiyama, Naohiko Tanabe et al. · Retina · 2016 · 38 citations

Medicine, Ophthalmology, Pharmacotherapy +14

Treatment Patterns and Health Care Costs for Age-Related Macular Degeneration in Japan

Atsuki Kume, Tomohiro Ohshiro, Yoichi Sakurada et al. · Ophthalmology · 2016 · 34 citations

Medicine, Ophthalmology, Pharmacoeconomics +11

Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration

Wataru Kikushima, Yoichi Sakurada, Seigo Yoneyama et al. · Scientific Reports · 2017 · 28 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17